Lexicon Pharmaceuticals Ownership | Who Owns Lexicon Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Lexicon Pharmaceuticals Ownership Summary

Lexicon Pharmaceuticals is owned by 113.68% institutional investors, 1.15% insiders. Artal group is the largest institutional shareholder, holding 71.36% of LXRX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.12% of its assets in Lexicon Pharmaceuticals shares.

LXRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lexicon Pharmaceuticals	113.68%	1.15%	-14.83%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Artal group	175.10M	71.36%	$294.17M
Fmr	38.69M	15.77%	$64.99M
Blackrock	9.89M	4.03%	$16.62M
Braidwell lp	8.29M	3.38%	$13.94M
Vanguard group	7.68M	3.13%	$12.89M
Orbimed advisors	5.85M	2.38%	$9.82M
Point72 asset management	4.12M	1.68%	$6.92M
Geode capital management	3.25M	1.32%	$5.46M
Nea management company	2.38M	0.97%	$4.00M
State street	2.31M	0.94%	$3.89M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Artal group	175.10M	7.50%	$294.17M
Braidwell lp	8.29M	0.44%	$13.94M
Nea management company	2.38M	0.30%	$4.00M
Nantahala capital management	2.30M	0.23%	$3.87M
Orbimed advisors	5.85M	0.20%	$9.82M
Virtus etf advisers	179.97K	0.15%	$302.35K
Hennion & walsh asset management	542.90K	0.05%	$912.07K
Pinnacle associates	1.72M	0.05%	$2.88M
Bbr partners	270.00K	0.04%	$453.60K
Prosperity financial group	31.50K	0.03%	$52.92K

Top Buyers

Holder	Shares	% Assets	Change
Artal group	175.10M	7.50%	57.55M
Fmr	38.69M	0.00%	24.79M
Braidwell lp	8.29M	0.44%	8.29M
Point72 asset management	4.12M	0.02%	3.54M
Nantahala capital management	2.30M	0.23%	2.30M

Top Sellers

Holder	Shares	% Assets	Change
Opaleye management	-	-	-1.88M
Bvf inc/il	-	-	-1.69M
Cubist systematic strategies	-	-	-1.40M
Schonfeld strategic advisors	571.49K	0.02%	-388.66K
Exoduspoint capital management, lp	-	-	-319.06K

New Positions

Holder	Shares	% Assets	Change	Value
Braidwell lp	8.29M	0.44%	8.29M	$13.94M
Nantahala capital management	2.30M	0.23%	2.30M	$3.87M
Hennion & walsh asset management	542.90K	0.05%	542.90K	$912.07K
Corebridge financial	61.77K	0.00%	61.77K	$103.77K
Mirae asset global etfs	47.18K	0.00%	47.18K	$79.27K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-21.00
Rothschild investment	-75.00
Ifp advisors	-150.00
Optiver b.v.	-155.00
Innealta capital	-175.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	130	6.56%	278,967,822	61.45%	113	1.86%	72	9.09%	23	-20.69%
Mar 31, 2024	122	10.91%	172,789,084	-5.49%	78	1.40%	66	17.86%	29	26.09%
Dec 31, 2023	110	-3.51%	182,824,838	-3.14%	74	0.88%	56	1.82%	23	-20.69%
Sep 30, 2023	114	-10.24%	188,754,252	-1.34%	92	0.90%	55	-31.25%	29	31.82%
Jun 30, 2023	127	19.81%	191,323,354	31.42%	101	1.71%	80	50.94%	22	-31.25%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	22.11M	6.12%	1.70M
Fidelity Growth Compy Commingled Pl O	20.40M	5.64%	2.23M
Fidelity Growth Company Fund	15.71M	4.35%	1.13M
Fidelity Growth Company K6	5.17M	1.43%	281.62K
Vanguard Total Stock Mkt Idx Inv	4.95M	1.37%	1.05M
Biotech Growth Ord	4.28M	1.18%	2.18M
Fidelity Series Growth Company	4.22M	1.17%	286.70K
Vanguard Institutional Extnd Mkt Idx Tr	2.98M	0.82%	48.47K
iShares Russell 2000 ETF	2.96M	0.82%	-6.66K
Fidelity Select Biotechnology	2.52M	0.70%	-1.79M

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	5	-
2023 Q3	2	-

LXRX Ownership FAQ

Who Owns Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals shareholders are primarily institutional investors at 113.68%, followed by 1.15% insiders and -14.83% retail investors. The average institutional ownership in Lexicon Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which Lexicon Pharmaceuticals exceeds.

Who owns the most shares of Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals’s largest shareholders are Artal group (175.1M shares, 71.36%), Fmr (38.69M shares, 15.77%), and Blackrock (9.89M shares, 4.03%). Together, they hold 91.15% of Lexicon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Lexicon Pharmaceuticals?

Yes, BlackRock owns 4.03% of Lexicon Pharmaceuticals, totaling 9.89M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.62M$. In the last quarter, BlackRock increased its holdings by 2.2M shares, a 28.56% change.

Who is Lexicon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Artal group is Lexicon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 7.50% of its assets in 175.1M Lexicon Pharmaceuticals shares, valued at 294.17M$.

Who is the top mutual fund holder of Lexicon Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Lexicon Pharmaceuticals shares, with 6.12% of its total shares outstanding invested in 22.11M Lexicon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools